Welcome, Tester!

New test results: We received your newest liquid biopsy results on January 24th and you have a new NF1 mutation that may make you eligible for a clinical trial. See your biomarker test results.

Recommended reading: We added a new article explaining the NF1 gene. Learn more about the NF1 gene over on the Encyclopedia of Precision Medicine.

Your treatment plan and goals at a glance


Taking since: 2023-08-30

See your full health history

Your personal biology


Your BRCA2 mutation may make you eligible to take a PARP inhibitor.


Status: High
Patients who are TMB-high often respond well to ICIs.

See your full biomarker testing history